Dragon Pharma Anavar 50 contains Oxandrolone in oral tablet form, labeled at 50 mg per tablet. As a tablet-based compound, independent lab testing helps verify the actual active substance content and provides insight into batch-to-batch consistency over time.
Below are independent lab reports confirming the potency of Anavar 50, tested across multiple batches and laboratories.
Latest Lab Results
1. Analiza Bialek Lab Report – 2026-01-13
- Product: Anavar 50
- Active Substance: Oxandrolone
- Manufacturer: Dragon Pharma
- Labeled Dosage: 50 mg/tablet
- Result: 48.26 mg/tablet
- Laboratory: Analiza Bialek
This most recent lab test shows a measured content of 48.26 mg, slightly below the labeled dosage, indicating a small negative deviation.
2. Analiza Bialek Lab Report – 2024-12-17
- Result: 46.44 mg/tablet
- Overview: This batch tested moderately below the labeled dosage, showing a larger negative deviation compared to other reports.
3. Janoshik Lab Report – 2024-06-12
- Result: 55.26 mg/tablet
- Overview: This result shows a positive deviation above the labeled dosage, indicating higher measured potency for this batch.
4. Janoshik Lab Report – 2022-08-27
- Result: 51.88 mg/tablet
- Overview: This earlier report shows a measured dosage close to the labeled amount with a slight positive deviation.
Potency Consistency Analysis
Across all available lab reports, Dragon Pharma Anavar 50 demonstrates variable but generally controlled dosing within a moderate range.
- Labeled dosage: 50 mg
- Tested range: 46.44–55.26 mg
- Deviation range: ~-7% to +10%
- Laboratories: Analiza Bialek and Janoshik
The results show both positive and negative deviations across different batches, providing a broader view of real-world manufacturing variation.
About Anavar 50 (Oxandrolone)
Oxandrolone is commonly produced in oral tablet form, where consistent dosing is important for maintaining predictable potency. Tablet formulations may show some variation depending on manufacturing processes and batch conditions.
Independent lab testing helps verify actual content and provides transparency across different production periods.
Conclusion
Independent lab reports from 2022 to 2026 show that Dragon Pharma Anavar 50 has tested within a range of 46.44 mg to 55.26 mg per tablet. This variation includes both slight underdosing and moderate overdosing across different batches.
Overall, the results provide a mixed but transparent view of batch-to-batch variation, supported by testing from both Janoshik and Analiza Bialek.
For additional specifications and formulation details, the complete Anavar 50 product information provides further details.
Frequently Asked Questions
Lab results show varying values across batches, ranging from 46.44 mg to 55.26 mg per tablet.
Tablet formulations can show variation depending on manufacturing processes and batch conditions.
The available reports were conducted by Janoshik and Analiza Bialek.
The results show some variation across batches, including both under and over labeled dosage.
